[Image from Medtronic] A Minnesota judge has dismissed a class action lawsuit alleging securities fraud related to insulin pumps made by Medtronic (NYSE:MDT). Laura M. Provinzino, U.S. District Judge ...

Medtronic PLC investors again failed to adequately allege the device maker’s statements about its MiniMed insulin pumps constituted securities fraud, a federal court said. The latest version of the ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID ...

The t:slim X2 automated insulin delivery system with Control IQ+ technology. [Image courtesy of Tandem Diabetes Care] Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received approval to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Children with type 1 diabetes can benefit from ...

This is a monthly column that runs down five interesting startup funding deals every month that may have flown under the radar. Check out our August entry here. While AI startups continue to get the ...

Sequel Med Tech has a plan to explore a new type of ultra-concentrated and fast-acting insulin, to see how it may work with its automated pump and potentially offer a longer-lasting system for people ...

AT278 (500U/mL) is the only ultra-concentrated and ultra-rapid acting insulin in development designed to enable the next generation of longer-wear and miniaturised automated insulin delivery (AID) ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...